CLINICAL TRIALS PROFILE FOR NOCDURNA
✉ Email this page to a colleague
All Clinical Trials for NOCDURNA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03201419 ↗ | A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults | Completed | Ferring Pharmaceuticals | Phase 2 | 2017-07-27 | The purpose of this trial was to investigate the efficacy, safety and tolerability of different oral doses of FE 201836, with desmopressin as a benchmark, during 12 weeks of treatment for nocturia due to nocturnal polyuria in adults |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NOCDURNA
Condition Name
Clinical Trial Locations for NOCDURNA
Trials by Country
Clinical Trial Progress for NOCDURNA
Clinical Trial Phase
Clinical Trial Sponsors for NOCDURNA
Sponsor Name